These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2332737)

  • 1. Regulation of antigen presentation by acidic pH.
    Jensen PE
    J Exp Med; 1990 May; 171(5):1779-84. PubMed ID: 2332737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.
    Jensen PE
    J Exp Med; 1991 Nov; 174(5):1111-20. PubMed ID: 1940792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficient peptide binding by cell-surface class II MHC molecules.
    Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE
    Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization.
    Jensen PE
    J Exp Med; 1992 Sep; 176(3):793-8. PubMed ID: 1512543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
    Haque MA; Hawes JW; Blum JS
    J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes.
    Falo LD; Sullivan K; Benacerraf B; Mescher MF; Rock KL
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6647-51. PubMed ID: 2413442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cells.
    Marsh EW; Dalke DP; Pierce SK
    J Exp Med; 1992 Feb; 175(2):425-36. PubMed ID: 1310101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimal number of class II MHC-antigen complexes needed for T cell activation.
    Demotz S; Grey HM; Sette A
    Science; 1990 Aug; 249(4972):1028-30. PubMed ID: 2118680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
    Adorini L; Moreno J; Momburg F; Hämmerling GJ; Guéry JC; Valli A; Fuchs S
    J Exp Med; 1991 Oct; 174(4):945-8. PubMed ID: 1919443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.